Opening Keynote: Dennis P. Scanlon, PhD

Dennis Scanlon is Distinguished Professor of Health Policy and Administration in the College of Health and Human Development, Director of the Center for Health Care and Policy Research, and the NCAA Faculty Athletics Representative at The Pennsylvania State University.

Closing Keynote: Rachel Dungan, M.S.S.P.

Director, AcademyHealth, Rachel Dungan, works at the intersection of sectors and stakeholder groups – supporting the advancement of health policy and systems research (HPSR), and the enhancement of its impact. As Director, Rachel oversees a work portfolio focused on studying the effective and ethical engagement of diverse stakeholders in health research activities. She also contributes to AcademyHealth’s Revolutionizing the Health Services Research Paradigm Learning Community initiative. This work involves HSR leaders and others, in applying human-centered design approaches to develop and test disruptive innovations that may potentially revolutionize the health research enterprise.


MariaFernanda Abalem, MD, PhD

Michigan Retinal Degeneration Questionnaire -MRDQ
Assistant Professor, University of Michigan and University of Sao Paulo 

Thomas AlbiniThomas Arno Albini, MD

Economic burden of non-infectious inflammatory eye disease (NIIED) in a commercially-insured population in the United States 
Department of Ophthalmology, School of Medicine, University of Miami

Penny AsbellPenny Asbell, MD, FACS, MBA, FARVO

DREAMing about Patients First
Barrett G. Haik Endowed Chair, Professor of Ophthalmology, Department of Ophthalmology, The University of Tennessee Health Science Center, Hamilton Eye Institute

Helen Baker
Helen Baker, PhD

Why patient-centered approaches and early patient involvement in project planning is important in outcomes research
NIHR Biomedical Research Centre, Moorfields Eye Hospital NHSFT; UCL Institute of Ophthalmology 

Tasanee BraithwaiteTasanee Braithwaite, MPH, MRCP, FRCOphthDM

Estimating utility and QALY loss in epidemiological surveys: Insights from The National Eye Survey of Trinidad and Tobago
Consultant Ophthalmologist, The Medical Eye Unit, Guy's and St Thomas' NHS Foundation Trust, London; Hon. Senior Lecturer, School of Life Course Sciences, King's College London  

Melissa BrownMelissa M. Brown MD, MN, MBA

Cost-utility analysis for  treatment of AMD with VEGF inhibitors, anti-glaucoma agents for glaucoma and second-eye cataract extraction for cataract surgery
Professor of Ophthalmology, Thomas Jefferson University, Wills Eye Hospital, Philadelphia. Pa., Adjunct Professor of Ophthalmology, Emory University, Atlanta, Ga.,  President/CEO, Center for Value-Based Medicine, Hilton Head, S.C. 

Joshua Ehrlich

Joshua Ehrlich, MD, MPH

Case studies in PROMs for vision impairment
Department of Ophthalmology and Visual Sciences, Institute for Social Research, University of Michigan  

Orla Galvin

Orla Galvin, BSc, PhD

Health economics and the patient
Director of Research Policy at Retina International; Secretary General Board of Directors European Federation of Neurological Associations  

Vijaya GothwalVijaya Gothwal, PhD

The science of PRO measurement
Visual functioning outcomes following cataract surgery: An item bank approach
Head, Patient-Reported Outcomes Unit - Brien Holden Eye Research Centre, L V Prasad Eye Institute, L V Prasad Marg, Banjara Hills, Hyderabad, India  

Marilyn James

Marilyn James

The health economics of diabetic retinopathy screening in the United Kingdom
Professor of Health Economics, Nottingham Clinical Trials Unit, School of Medicine University of Nottingham

Jyoti KhadkaJyoti Khadka, PhD

The intersection of PROMS and Health Economics
Health and Social Care Economics Group, Caring Futute Insititute, College of Nursing and Health Sciences, Flinders University, Adelaide, Australia; Registry of Senior Australians, South Australian Health and Medical Research Institute, Adelaide, Australia

Himal Kandel

Himal Kandel, PhD

Patient reported outcomes of corneal cross-linking for Keratoconus: a Save Sight Keratoconus Registry study
Save Sight Institute, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia  

Ecosse LamoureuxEcosse Lamoureux, BEd, GradDip, MApplSc, PhD 

Cost effectiveness of vision screening for diabetic retinopathy in Singapore
Duke-NUS Medical School and Singapore Eye Research Institute, Singapore

Maureen MaguireMaureen G. Maguire, PhD

Welcome to the Health economics and outcomes research conference
Professor Emeritus, University of Pennsylvania Senior Biostatistician Jaeb Center for Health Research 

Joao Pedro Marques

João Pedro Marques MD, MSc, FEBO

Linguistic validation: A necessity for global patient reported outcomes research
Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal, Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal 

David Musch

David C. Musch, PhD, MPH

Patient-reported outcome measures for ophthalmic diseases and disorders 
Professor, Dept. of Ophthalmology and Visual Sciences, Professor, Dept. of Epidemiology, University of Michigan, Ann Arbor, Mich.  

David Rein

David B. Rein, PhD

The economic burden of vision loss and blindness in the United States
Director, Public Health Analytics Program NORC at the University of Chicago, Atlanta Office

Ian SaldanhaIan Saldanha, MBBS, MPH, PhD

Outcomes that matter to patients with Dry Eye
Center for Evidence Synthesis in Health Department of Health Services, Policy, and Practice, Department of Epidemiology, Brown University School of Public Health 

Bonnielin Swenor

Bonnielin Swenor, PhD, MPH

Stop thinking about a black box and start thinking about what you want to measure
Director, The Johns Hopkins Disability Health Research Center, Associate Professor, The Wilmer Eye Institute, Johns Hopkins School of Medicine


Julio Benedicto

Julio Benedicto

Vice President, Marketing and Lumevoq Operations GenSight Biologics 

Fraser Bocell

Fraser Bocell, MEd, PhD


Lisa KeayLisa Keay, PhD, MPH, BOptom

School of Optometry and Vision Science, UNSW Sydney, The George Institute for Global Health, UNSW Sydney 

Mitchell LevineMitchell Levine MD, MSc, FRCPC, FACP, FISPE

Assistant Dean and Professor, Dept. of Health Research Methods, Evidence & Impact, Dept. of Medicine, Div. Clinical Pharmacology & Toxicology, Faculty of Health Sciences, McMaster University

Christopher McCabeChristopher McCabe, PhD

Institute of Health Economics

Eric NelsonEric Nelson, PhD

Veteran biopharma business development, and strategic R&D planning drug discovery executive. BD consultant to Foundation Fighting Blindness, the University of North Carolina at Chapel Hill, and retina gene therapy biotechs.

Tieuvi Nguyen

Tieuvi Nguyen, PhD

Director, Division of Ophthalmic Devices, Food and Drug Administration

Sarah NorrisSarah Norris, PhD

Menzies Centre for Health Policy & Economics, University of Sydney

H. Nida SenH. Nida Sen, MD, MHS

Clinical Professor of Ophthalmology, George Washington University, Volunteer Faculty, National Eye Institute, NIH, Senior Director, Clinical Leader, Janssen Retina

Michelle SenchynaMichelle Senchyna, PhD

Vice President, Clinical Development and Medical Affairs, Aerie Pharmaceuticals